Efficacy, safety, and prognosis prediction in patients treated with ribociclib in combination with letrozole: Final results of phase 3b RIBECCA study in hormone receptor positive, human epidermal growth factor receptor-2 negative, locally advanced or metastatic breast cancer

Peter A. Fasching, Thomas Decker, Andreas D. Hartkopf, Arnd Nusch, Bernhard Heinrich, Christian M. Kurbacher, Roswitha Fuchs, Hans Tesch, Petra Krabisch, Jens Huober, Sherko Küemmel, Sara Y. Brucker, Wolfgang Janni, Andreas Schneeweiß, Martin Schüler, Tanja Fehm, Diana Lüftner, Claudia Quiering, Claudia Voges, Julia Kreuzeder, Mattea Reinisch